The Effectiveness of Intravitreal Avastin Injection for CRVO

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2012 by Ziv Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Ziv Hospital
ClinicalTrials.gov Identifier:
NCT01678248
First received: August 29, 2012
Last updated: NA
Last verified: August 2012
History: No changes posted
  Purpose

to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion


Condition
Central Retinal Vein Occlusion

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Effectiveness of Intravitreal Avastin Injection for CRVO

Further study details as provided by Ziv Hospital:

Estimated Enrollment: 68
Study Start Date: January 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

patients who suffer from CRVO and were injected by bevazicumab intravitrealy

Criteria

Inclusion Criteria:

  • patients above 18 years old
  • suffer from CRVO
  • maximal visual acuity 6/15

Exclusion Criteria:

  • VA of LP
  • retinal disease other than CRVO
  • incomplete medical record
  • follow up less than 6 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01678248

Contacts
Contact: Joseph pikkel, M.D 972508434206 pikel.y@ziv.health.gov.il
Contact: Otzem Chassid, M.D 972506266059 otzem.c@ziv.health.gov.il

Locations
Israel
Ziv Medical Center Recruiting
Safed, Israel, 13100
Contact: Otzem Chassid, M.D       otzem.c@ziv.health.gov.il   
Principal Investigator: Joseph Pikkel, M.D         
Sponsors and Collaborators
Ziv Hospital
  More Information

No publications provided

Responsible Party: Ziv Hospital
ClinicalTrials.gov Identifier: NCT01678248     History of Changes
Other Study ID Numbers: 0048-12-ZIV
Study First Received: August 29, 2012
Last Updated: August 29, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Retinal Vein Occlusion
Retinal Diseases
Eye Diseases
Venous Thrombosis
Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 25, 2014